TREATMENT OF ADVANCED OVARIAN CARCINOMA WITH HIGH-DOSE CYCLOPHOSPHAMIDE AFTER FAILURE ON MELPHALAN

被引：0
|
作者：
TWIGGS, LB [1 ]
MORROW, CP [1 ]
机构：
[1] UNIV SO CALIF,LOS ANGELES CTY MED CTR,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,LOS ANGELES,CA 90033
来源：
CANCER TREATMENT REPORTS | 1977年 / 61卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1369 / 1371
页数：3
相关论文
共 50 条
  • [41] Ovarian failure common with high-dose busulfan
    Reactions Weekly, 1999, 737 (1) : 6 - 6
  • [42] MELPHALAN CHEMOTHERAPY IN ADVANCED OVARIAN CARCINOMA
    PIVER, MS
    BARLOW, JJ
    YAZIGI, R
    BLUMENSON, LE
    OBSTETRICS AND GYNECOLOGY, 1978, 51 (03): : 352 - 356
  • [43] Are there candidates for high-dose chemotherapy in ovarian carcinoma?
    Renaud Sabatier
    Anthony Gonçalves
    François Bertucci
    Maria-Antonietta Capiello
    Frédérique Rousseau
    Eric Lambaudie
    Christian Chabannon
    Patrice Viens
    Jean-Marc Extra
    Journal of Experimental & Clinical Cancer Research, 31
  • [44] A RANDOMIZED STUDY OF HIGH-DOSE VERSUS LOW-DOSE CIS-PLATINUM COMBINED WITH CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
    NGAN, HYS
    CHOO, YC
    CHEUNG, M
    WONG, LC
    MA, HK
    COLLINS, R
    FUNG, C
    NG, CS
    WONG, V
    HO, HC
    LEUNG, P
    WONG, R
    CHAN, E
    SIMON, MTP
    HO, LC
    CHAN, YF
    CHEMOTHERAPY, 1989, 35 (03) : 221 - 227
  • [45] Are there candidates for high-dose chemotherapy in ovarian carcinoma?
    Sabatier, Renaud
    Goncalves, Anthony
    Bertucci, Francois
    Capiello, Maria-Antonietta
    Rousseau, Frederique
    Lambaudie, Eric
    Chabannon, Christian
    Viens, Patrice
    Extra, Jean-Marc
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [46] TREATMENT OF MYELOMA RELAPSING AFTER HIGH-DOSE MELPHALAN WITH CONTINUOUS INFUSION VINCRISTINE, ADRIAMYCIN AND ORAL METHYLPREDNISOLONE (VAMP) FOLLOWED BY A 2ND HIGH-DOSE MELPHALAN
    HARDING, M
    GORE, M
    JUDSON, I
    VINER, C
    SELBY, P
    NANDI, A
    MCELWAIN, T
    BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 454 - 454
  • [47] THE PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE AND HIGH-DOSE ETOPOSIDE
    CUNNINGHAM, D
    CUMMINGS, J
    BLACKIE, RB
    MCTAGGART, L
    BANHAM, SW
    KAYE, SB
    SOUKOP, M
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (02): : 117 - 123
  • [48] QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide.
    Nakamae, H
    Hino, M
    Yamane, T
    Ohta, K
    Akahori, M
    Aoyama, Y
    Yamamura, R
    Takeoka, Y
    Nakao, M
    Tatsumi, N
    BLOOD, 2000, 96 (11) : 394A - 394A
  • [49] HIGH-DOSE, DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR THE TREATMENT OF ADVANCED BREAST-CANCER
    FERGUSON, JE
    DODWELL, DJ
    SEYMOUR, AM
    RICHARDS, MA
    HOWELL, A
    BRITISH JOURNAL OF CANCER, 1993, 67 (04) : 825 - 829
  • [50] High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma
    Donato, ML
    Aleman, A
    Champlin, RE
    Weber, D
    Alexanian, R
    Ippoliti, CM
    De Lima, M
    Anagnostopoulos, A
    Giralt, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 755 - 759
12345